tiprankstipranks
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
US Market

Royalty Pharma (RPRX) Technical Analysis

Compare
1,251 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Royalty Pharma PLC’s (RPRX) Moving Averages Convergence Divergence (MACD) indicator is 0.26, suggesting Royalty Pharma PLC is a Buy.
Royalty Pharma PLC’s (RPRX) 20-Day exponential moving average is 33.01, while Royalty Pharma PLC’s (RPRX) share price is $33.76, making it a Sell.
Royalty Pharma PLC’s (RPRX) 50-Day exponential moving average is 31.84, while Royalty Pharma PLC’s (RPRX) share price is $33.76, making it a Sell.

Royalty Pharma (RPRX) Pivot Points

Mar 27, 2025, 06:18 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
32.82
33.16
33.46
33.80
34.10
34.44
34.74
Fibonacci
33.16
33.40
33.56
33.80
34.04
34.20
34.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Royalty Pharma (RPRX) Moving Averages

Mar 27, 2025, 06:18 PM
Period
Simple
Exponential
MA5
33.25Sell
32.92Sell
MA10
33.16Sell
33.09Sell
MA20
33.19Sell
33.01Sell
MA50
32.26Sell
31.84Sell
MA100
29.07Buy
30.27Buy
MA200
28.07Buy
29.00Buy
Royalty Pharma PLC’s (RPRX) 10-Day exponential moving average is 33.09, while Royalty Pharma PLC’s (RPRX) share price is $33.76, making it a Sell.
Royalty Pharma PLC’s (RPRX) 100-Day exponential moving average is 30.27, while Royalty Pharma PLC’s (RPRX) share price is $33.76, making it a Buy.
Royalty Pharma PLC’s (RPRX) stock price is $33.76 and Royalty Pharma PLC’s (RPRX) 50-day simple moving average is 32.26, creating a Sell signal.
Royalty Pharma PLC’s (RPRX) stock price is $33.76 and Royalty Pharma PLC’s (RPRX) 100-day simple moving average is 29.07, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) stock price is $33.76 and Royalty Pharma PLC’s (RPRX) 200-day simple moving average is 28.07, creating a Buy signal.

Royalty Pharma (RPRX) Technical Indicators

Mar 27, 2025, 06:18 PM
Name
Value
Implied Action
RSI (14)
36.94
Neutral
STOCH (9,6)
58.08
Neutral
STOCHRSI (14)
58.90
Neutral
MACD (12,26)
0.26
Buy
ADX (14)
24.87
Neutral
Williams %R
-93.48
Buy
CCI (14)
-155.89
Buy
ATR (14)
0.76
-
Ultimate Oscillator
39.67
Neutral
ROC
-5.17
Sell
Royalty Pharma PLC’s (RPRX) Relative Strength Index (RSI) is 36.94, creating a Neutral signal.
Royalty Pharma PLC’s (RPRX) Trend Strength Indicator (ADX) is 24.87, creating a Neutral signal.
Royalty Pharma PLC’s (RPRX) Commodity Channel Index (CCI) is -155.89, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) Price Rate of Change (ROC) is -5.17, creating a Sell signal.

FAQ

Is RPRX a Buy, Hold, or Sell?
Based on RPRX’s technical indicators, RPRX is a Sell.
    What is RPRX’s RSI (14)?
    RPRX’s RSI (14) is 36.94, which suggests RPRX is a Neutral.
      What is RPRX’s MACD?
      RPRX’s MACD is 0.26, which suggests RPRX is a Buy.
        What is RPRX’s 5-day moving average?
        RPRX’s 5-day moving average is 33.25, which suggests RPRX is a Sell.
          What is RPRX’s 20-day moving average?
          RPRX 20-day moving average is 33.19, which suggests RPRX is a Sell.
            What is RPRX’s 50-day moving average?
            RPRX’s 50-day moving average is 32.26, which suggests RPRX is a Sell.
              What is RPRX’s 200-day moving average?
              RPRX’s 200-day moving average is 28.07, which suggests RPRX is a Buy.
                What is RPRX’s Williams % R (14)?
                RPRX’s Williams % R (14) is -93.48, which suggests RPRX is a Buy.
                  What is RPRX’s CCI (14)?
                  RPRX’s CCI (14) is -155.89, which suggests RPRX is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis